Pharbel SA
6.9 FTEThe score of Pharbel shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +64 % Total assets -10 % Headcount (avg FTE) -3 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharbel's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 01 Aug 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
Pharbel's financial analysis
- Solvency46.8%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharbel
Pharbel's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.266.386
- VAT number
- BE0449266386
- Peppol
- Registered · 0208:0449266386 · as of 08 Nov 2026
- Legal form
- SA
- Incorporated
- 15 Dec 1992
- Registered office
- 1030 Schaerbeek
- Size
- Micro · 6.9 FTE
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Pharbel (SA) has been based in Schaerbeek since 1992, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 139,948 € and equity of €1.33m; its revenue is not published. With 6.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 46.8%, above the median of its sector (32.3%).
Companies similar to Pharbel
Companies in the same business, of comparable size and area, outside its group.
- Copharem Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €1.24m
- Wenduine Pharma Retail sale of pharmaceutical products De Haan · balance sheet €1.25m
- Pharmacie des Lacs Retail sale of pharmaceutical products Cerfontaine · balance sheet €2.69m
- HolsbeekVD Brecht Retail sale of pharmaceutical products Brecht · balance sheet €2.46m
- Pharma2Care Retail sale of pharmaceutical products Zuienkerke · balance sheet €1.79m
- DE MOL - Regnier Pharma Retail sale of pharmaceutical products Courcelles · balance sheet 642,568 €
- Apotheke Hardy Pharmacie Retail sale of pharmaceutical products Amel · balance sheet €1.60m
- Alphar Immo Retail sale of pharmaceutical products Libramont-Chevigny · balance sheet €2.23m
Frequently asked questions about Pharbel
What is the revenue of Pharbel?
Pharbel files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharbel?
In Belgium, the VAT number is the company number prefixed with BE: BE0449266386 for Pharbel, if the company is VAT-registered. Its company number (CBE) is 0449.266.386.
Where is the registered office of Pharbel?
According to the CBE register, the registered office of Pharbel is in 1030 Schaerbeek.
What is the equity of Pharbel?
At the close of the 2025 financial year, the equity of Pharbel amounts to 1,326,093 €, a solvency of 46.8% of total assets.
How many people work at Pharbel?
6.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharbel?
The register lists 2 active mandates at Pharbel. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharbel
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →